More about

Vomiting

News
April 05, 2024
2 min read
Save

Most patients with norovirus have just one health care encounter, study finds

Most patients with norovirus have just one health care encounter, study finds

Most patients with all-cause and norovirus-associated acute gastroenteritis have only one health care encounter, primarily in the outpatient setting, researchers found in a study.

News
March 27, 2024
2 min read
Save

GI illness outbreak, deaths linked to consumption of undercooked morel mushrooms

GI illness outbreak, deaths linked to consumption of undercooked morel mushrooms

Consumption of uncooked or undercooked morel mushrooms was “strongly associated” with a gastrointestinal illness outbreak in spring 2023 that resulted in two deaths, highlighting the importance of proper food preparation procedures.

News
March 20, 2024
3 min read
Save

Q&A: ‘Go back to basics’ — remind patients how to prevent norovirus

Q&A: ‘Go back to basics’ — remind patients how to prevent norovirus

Cases of norovirus have risen across the United States, although symptom-based care and proper hygiene can help treat and prevent the spread of the disease, an expert said.

News
March 04, 2024
9 min read
Save

Q&A: Misconceptions, risk factors, treatment for nausea, vomiting of pregnancy

Q&A: Misconceptions, risk factors, treatment for nausea, vomiting of pregnancy

Nausea and vomiting of pregnancy, commonly called morning sickness, is a complex condition that can occur at any time of the day and includes and combination of nausea, vomiting and retching.

News
February 23, 2024
2 min read
Save

Investigational monthly obesity drug led to durable weight loss in phase 1 trial

Investigational monthly obesity drug led to durable weight loss in phase 1 trial

Adults with obesity who received an injectable GIP receptor antagonist/GLP-1 receptor agonist every 4 weeks had a decrease in body weight that was maintained for up to 150 days, according to study findings published in Nature Metabolism.

News
February 17, 2024
4 min read
Save

Game helps older adults be 'proactive' to prevent chemotherapy-associated nausea, vomiting

Game helps older adults be 'proactive' to prevent chemotherapy-associated nausea, vomiting

Researchers at University of Central Florda developed an educational game to help older adults with cancer manage chemotherapy-related nausea and vomiting.

News
December 19, 2023
1 min read
Save

Preliminary data shows lowered cytokine levels in myelofibrosis with PIM1 kinase inhibitor

SAN DIEGO — Treatment with a selective PIM1 kinase inhibitor showed positive clinical reactions in a sample of 23 patients with relapsed/refractory myelofibrosis, according to preliminary data presented at ASH Annual Meeting.

News
December 08, 2023
2 min read
Save

Low-dose olanzapine has ‘practice-defining implications’ for controlling CINV

Low-dose olanzapine has ‘practice-defining implications’ for controlling CINV

SAN ANTONIO — Low-dose olanzapine appeared noninferior to the standard dose for controlling chemotherapy-induced nausea and vomiting without requiring delayed steroids among patients with solid tumors, according to study results.

News
December 05, 2023
2 min read
Save

Acamprosate, oral naltrexone linked to improved outcomes in alcohol use disorder

Acamprosate, oral naltrexone linked to improved outcomes in alcohol use disorder

Acamprosate and oral naltrexone were associated with significantly improved alcohol consumption outcomes compared with placebo and could be used alongside psychosocial interventions as first-line treatment for alcohol use disorder.

News
October 26, 2023
1 min read
Save

FDA grants MR conditional use to Enterra’s electrical stimulation device for gastroparesis

FDA grants MR conditional use to Enterra’s electrical stimulation device for gastroparesis

The FDA has granted conditional use with magnetic resonance imaging to Enterra Medical’s implantable electrical stimulation device for management of symptoms associated with gastroparesis, according to a company release.

View more